Get the Stockscreener App
0.1974
4.44%
0.0084
After Hours:
.18
-0.0174
-8.81%
BiomX Inc stock is traded at $0.1974, with a volume of 813.43K.
It is up +4.44% in the last 24 hours and down -50.10% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.189
Open:
$0.1847
24h Volume:
813.43K
Relative Volume:
0.12
Market Cap:
$2.13M
Revenue:
-
Net Income/Loss:
$-47.68M
P/E Ratio:
-0.00791
EPS:
-24.9619
Net Cash Flow:
$-23.09M
1W Performance:
-1.30%
1M Performance:
-50.10%
6M Performance:
-97.16%
1Y Performance:
-97.58%
1-Day Range:
$0.1808
$0.1974
1-Week Range:
$0.177
$0.21
52-Week Range:
$0.177
$13.70
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.1974 | 2.04M | 0 | -47.68M | -23.09M | -24.96 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
BiomXMay Offer And Sell Up To $9.10 Million Of Common Stock Through WainwrightSEC Filing - TradingView
Biomx Inc (PHGE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomx Inc (PHGE) Cash Flow - TradingKey
Biomx Inc (PHGE) Balance Sheet - TradingKey
TradingKey - TradingKey
Biomx Inc (PHGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PHGE|Biomx Inc|Price:0.189|Chg%:-0.011 - TradingKey
Biomx Inc (PHGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomx Inc (PHGE) Institutional Confidence - TradingKey
Biomx Inc (PHGE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biomx Inc (PHGE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biomx Inc (PHGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PHGE|Biomx Inc|Price:0.181|Chg%:-0.008 - TradingKey
BiomX Inc. (PHGE) Stock Price, News, Quote & History - Yahoo! Finance Canada
BiomX's Zorronet expands in Europe with AI coll... - Pluang
BiomX Subsidiary Zorronet Enters Strategic Collaboration with Samura s.r.o. for AI-Powered Monitoring Solutions in Europe - Quiver Quantitative
Zorronet AI collaborations will target farm pests and rail trespassers - Stock Titan
BiomX (PHGE) Proxy filing Summary - Quartr
BiomX (PHGE) Stock Forum and Discussion - Moomoo
BiomX (PHGE) Analyst Ratings, Stock Forecast and Price Target - Moomoo
Form PRE 14A BIOMX INC. For: 17 July By Investing.com - Investing.com Nigeria
BiomX Inc. (PHGE) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
BiomX Inc. (NYSE: PHGE) seeks approval for Mandragola securities, $2M credit line and reverse split - Stock Titan
BiomX (PHGE) stock soars over 25% after-hours: Here's why it is trending - MSN
BiomX(PHGE) Stock Options Chain | Quotes & News - Moomoo
[EFFECT] BiomX Inc. SEC Filing - Stock Titan
BiomX signs LOI to acquire 60% of Israeli systems integrator Tsoock for $10.4M - MSN
BiomX Cancels Conversion Shares to Restore NYSE Compliance - TipRanks
BiomX cancels 1,013,637 conversion shares to regain NYSE American Section 712 compliance - TradingView
BiomX Inc. (NYSE: PHGE) cancels 1,013,637 shares tied to Dr. Frucht deal - Stock Titan
BiomX Dips on New Data Center - Baystreet.ca
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities - The Manila Times
BiomX Company Profile & Introduction - Moomoo
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure - marketscreener.com
PHGE Q4 2025 Earnings: EPS Misses by a Wide Margin as Clinical Costs MountEarnings Forecast Report - DonanımHaber
BiomX (PHGE) Stock Soars Over 25% After-Hours: Here's Why it is Trending - Sahm
BiomX Unit Signs LOI to Buy 60% Stake in Tsoock for $10.4 Million - marketscreener.com
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities - The Manila Times
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform With Critical Infrastructure and Secure-Site Integration Capabilities - 富途牛牛
BiomX plans to acquire 60% of Israeli security firm Tsoock to boost its security integration capabilities. - Pluang
PHGE Q4 2025 Earnings: Significant EPS Miss of 73.75% as Clinical-Stage Biotech Reports No RevenueDownward Estimate Revision - dars.gov.et
BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement - AI Magazine
BiomX Subsidiary Zorronet Begins AI and ML Detection System Installation on Israel Railways Network - Moomoo
BiomX subsidiary starts AI track detection on Israel Railways network - Stock Titan
PHGE Q4 2025 Earnings: Significant EPS Miss Amid Development-Stage Company ChallengesPre-Announcement Alert - dars.gov.et
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):